Patent ID: 8026267

Claim:
A method for treating metastatic breast cancer in an individual previously treated with an anthracycline comprising administering to an individual in need thereof a dosing regimen which comprises at least one 3-week long treatment cycle, and wherein said individual is administered nonpegylated liposomal doxorubicin at a dose level of from 30 mg/m 2 to 75 mg/m 2 on day 1 of each treatment cycle, paclitaxel at a dose level of from 50 mg/m 2 to 250 mg/m 2 on day 1 of each treatment cycle, and trastuzumab at a dose level of from 3 mg/kg to 5 mg/kg as a loading dose on day 1 of the first treatment cycle and every week thereafter at a dose level of from 1 mg/kg to 3 mg/kg, and wherein said individual previously has been administered an anthracycline.